These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28848921)

  • 1. Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.
    Jones PW; Gelhorn H; Wilson H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):124-131. PubMed ID: 28848921
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering the Relative Efficacy of Inhaled Medications for Chronic Obstructive Pulmonary Disease: Multiple Treatment Comparisons.
    Zhu Y; Zhang T; Li H; Yang Y; Chen Q; Kong L; Tai B
    Cell Physiol Biochem; 2017; 41(4):1532-1546. PubMed ID: 28334727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.
    Jones PW; Gelhorn H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Wilson H; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):132-140. PubMed ID: 28848922
    [No Abstract]   [Full Text] [Related]  

  • 6. The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.
    Tabberer M; Benson VS; Gelhorn H; Wilson H; Karlsson N; Müllerova H; Menjoge S; Rennard SI; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):112-123. PubMed ID: 28848920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.
    Jones PW; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Apr; 4(2):150-158. PubMed ID: 28848924
    [No Abstract]   [Full Text] [Related]  

  • 9. The COPD Biomarkers Qualification Consortium St George's Respiratory Questionnaire Manuscripts: Output of a Consortium to Advance Drug Development.
    Tabberer M; Jones PW
    Chronic Obstr Pulm Dis; 2017 Feb; 4(2):109-111. PubMed ID: 28848919
    [No Abstract]   [Full Text] [Related]  

  • 10. St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.
    Müllerova H; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Rennard SI; Tabberer M; Tal-Singer R; Merrill D; Jones PW
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):141-149. PubMed ID: 28848923
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis.
    Calzetta L; Di Marco F; Blasi F; Cazzola M; Centanni S; Micheletto C; Rossi A; Rogliani P
    Pulm Pharmacol Ther; 2019 Dec; 59():101855. PubMed ID: 31639476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis.
    Oba Y; Chandran AV; Devasahayam JV
    COPD; 2016 Dec; 13(6):677-685. PubMed ID: 27148815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses.
    Tashkin DP; Bateman ED; Jones P; Zubek VB; Metzdorf N; Liu D; Leonard T; Clerisme-Beaty E; Wise RA
    Respir Med; 2016 Nov; 120():91-100. PubMed ID: 27817821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
    Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
    Rodrigo GJ; Price D; Anzueto A; Singh D; Altman P; Bader G; Patalano F; Fogel R; Kostikas K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():907-922. PubMed ID: 28360514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysis.
    Horita N; Miyazawa N; Tomaru K; Inoue M; Kaneko T
    Respirology; 2015 Nov; 20(8):1153-9. PubMed ID: 26235837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease.
    Donohue JF; Jones PW; Bartels C; Marvel J; D'Andrea P; Banerji D; Morris DG; Patalano F; Fogel R
    Pulm Pharmacol Ther; 2018 Apr; 49():11-19. PubMed ID: 29277690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Appleton S; Smith B; Veale A; Bara A
    Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.